NMS · Financial Statements

Outset Medical, Inc. (OM) Revenue, Earnings & Financial Statements

$3.16 NMS: OM Market Cap $59.57M

Data as of Nov 17, 2026 close · Statements through the quarter ended Jun 2026 · Source: Financial Modeling Prep (methodology)

Outset Medical, Inc. most recently reported annual revenue of $119.0M, a net loss of $82.0M. Revenue grew at an average annual rate of 18.9% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Outset Medical, Inc.: Revenue rose from $2.0M in 2018 to $119.0M in 2025, a change of +5850.0% over 7 years; net profit was positive in 0 of 8 reported years; operating margin moved from -2320.0% to -55.8%, a shift of +2264.2 percentage points; the most recent year shows a net loss of $82.0M.

Income Statement — 8 Years (USD millions)

Metric20182019202020212022202320242025
Revenue$2.0M$15.0M$50.0M$103.0M$115.0M$130.0M$114.0M$119.0M
Operating Expenses$49.0M$85.0M$167.0M$233.0M$276.0M$300.0M$227.0M$186.0M
Operating Profit−$47.0M−$70.0M−$117.0M−$131.0M−$161.0M−$170.0M−$113.0M−$67.0M
Operating Margin-2320.0%-466.3%-235.2%-127.2%-139.6%-130.2%-99.7%-55.8%
Other Income−$3.0M$2.0M−$4.0M−$1.0M−$2.0M−$3.0M−$14.0M−$14.0M
Interest$5.0M$4.0M$3.0M$2.0M$4.0M$13.0M$24.0M$14.0M
Depreciation$1.0M$2.0M$3.0M$5.0M$5.0M$6.0M$6.0M$4.0M
Profit Before Tax−$50.0M−$68.0M−$121.0M−$132.0M−$163.0M−$172.0M−$127.0M−$81.0M
Tax rate (%)-0.1%-0.0%0.0%-0.1%-0.2%-0.3%-0.4%-0.9%
Net Profit−$50.0M−$68.0M−$121.0M−$132.0M−$163.0M−$173.0M−$128.0M−$82.0M
EPS−$1.65−$34.06−$2.83−$43.41−$50.75−$52.27−$36.95−$5.37

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricSep '23Dec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26
Revenue$30.0M$31.0M$28.0M$27.0M$29.0M$29.0M$30.0M$31.0M$29.0M$29.0M$28.0M$32.0M
Operating Expenses$76.0M$68.0M$65.0M$58.0M$53.0M$51.0M$46.0M$48.0M$45.0M$47.0M$45.0M$47.0M
Operating Profit−$45.0M−$37.0M−$37.0M−$31.0M−$24.0M−$22.0M−$16.0M−$17.0M−$16.0M−$18.0M−$17.0M−$16.0M
Operating Margin-149.7%-122.4%-131.0%-112.3%-83.2%-74.2%-55.1%-53.7%-53.7%-61.0%-60.7%-49.5%
Interest$3.0M$3.0M$6.0M$6.0M$6.0M$6.0M$4.0M$3.0M$3.0M$3.0M$3.0M$3.0M
Profit Before Tax−$46.0M−$38.0M−$40.0M−$34.0M−$28.0M−$26.0M−$26.0M−$18.0M−$17.0M−$19.0M−$19.0M−$18.0M
Tax rate (%)-0.2%-0.3%-0.4%-0.4%-0.7%0.0%-0.5%-0.6%-2.3%-0.5%-1.2%-1.2%
Net Profit−$46.0M−$39.0M−$40.0M−$34.0M−$28.0M−$26.0M−$26.0M−$19.0M−$18.0M−$19.0M−$19.0M−$18.0M
EPS−$0.93−$0.77−$11.77−$9.96−$8.30−$7.35−$7.44−$1.04−$1.00−$1.09−$1.03−$0.97

Over the 8 years reported for Outset Medical, Inc., borrowings increased from $29.0M in 2018 to $101.0M in 2025, cash stood at $35.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 6.61 times.

Balance Sheet — 8 Years (USD millions)

Metric20182019202020212022202320242025
Total Assets$151.0M$88.0M$404.0M$463.0M$400.0M$314.0M$276.0M$264.0M
Current Assets$148.0M$80.0M$346.0M$410.0M$374.0M$291.0M$258.0M$251.0M
Cash$33.0M$37.0M$295.0M$182.0M$73.0M$69.0M$124.0M$35.0M
Inventory$3.0M$5.0M$18.0M$39.0M$51.0M$49.0M$59.0M$48.0M
Receivables$1.0M$4.0M$6.0M$26.0M$28.0M$33.0M$36.0M$28.0M
Fixed Assets$3.0M$8.0M$23.0M$20.0M$22.0M$19.0M$12.0M$9.0M
Capital Work in Progress$0$0$0$0$0$0$0$0
Investments$110.0M$34.0M$20.0M$190.0M$218.0M$135.0M$38.0M$138.0M
Other Assets$0$0$0$0$0$0$0$0
Total Liabilities$439.0M$461.0M$75.0M$89.0M$154.0M$191.0M$249.0M$138.0M
Current Liabilities$10.0M$25.0M$37.0M$52.0M$52.0M$55.0M$45.0M$38.0M
Borrowings$29.0M$29.0M$39.0M$38.0M$103.0M$136.0M$202.0M$101.0M
Other Liabilities$410.0M$431.0M$37.0M$52.0M$51.0M$55.0M$47.0M$36.0M
Equity$0$0$0$0$0$0$0$0
Reserves−$288.0M−$372.0M$329.0M$374.0M$246.0M$123.0M$27.0M$127.0M

For Outset Medical, Inc., operating cash flow was positive in 0 of 8 reported years; free cash flow in the latest year was negative at $47.0M; free cash flow was positive in 0 of 8 years.

Cash Flow Statement — 8 Years (USD millions)

Metric20182019202020212022202320242025
Operating Cash Flow−$46.0M−$70.0M−$99.0M−$130.0M−$146.0M−$131.0M−$116.0M−$46.0M
Investing Cash Flow−$138.0M$71.0M−$5.0M−$146.0M−$75.0M$80.0M$103.0M−$98.0M
Financing Cash Flow$0$0$5.0M$11.0M$0$0−$1.0M$0
Net Cash Flow$20.0M$4.0M$291.0M−$113.0M−$139.0M−$5.0M$56.0M−$89.0M
Free Cash Flow−$48.0M−$74.0M−$108.0M−$133.0M−$154.0M−$135.0M−$117.0M−$47.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.02
EV / EBITDA-2.55
FCF Yield-59.11%
Quick Ratio5.34
Interest Coverage-4.79
Return 1Y-23.88%
Return 3Y-94.99%
Return 5Y-99.45%

Outset Medical, Inc. (OM) financials — frequently asked questions

What is Outset Medical, Inc.'s annual revenue?

Outset Medical, Inc. (OM) reported annual revenue of $119.0M in its most recent fiscal year.

What is Outset Medical, Inc.'s net profit?

Outset Medical, Inc. (OM) reported a net loss of $82.0M in its most recent fiscal year.

What is OM EV/EBITDA?

Outset Medical, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is -2.55. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.

Revenue and earnings of other Medical - Devices stocks

ABT revenue $44.3BISRG revenue $10.1BMDT revenue $36.4BSYK revenue $25.1BBSX revenue $20.1BEW revenue $6.1BRMD revenue $5.7BDXCM revenue $4.7BPHG revenue $17.8BZBH revenue $8.2BAll Medical - Devices stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
OM Overview OM Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.